These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. Potpara TS; Lip GY Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958 [TBL] [Abstract][Full Text] [Related]
5. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials. Renda G; di Nicola M; De Caterina R Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation. Senoo K; Lip GY Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085 [TBL] [Abstract][Full Text] [Related]
7. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Garcia DA Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997 [TBL] [Abstract][Full Text] [Related]
8. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation. Cappellari M; Carletti M; Danese A; Bovi P J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483 [TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Rivera-Caravaca JM; Esteve-Pastor MA; Camelo-Castillo A; Ramírez-Macías I; Lip GYH; Roldán V; Marín F Expert Opin Pharmacother; 2020 Oct; 21(15):1867-1881. PubMed ID: 32658596 [TBL] [Abstract][Full Text] [Related]
11. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Fernandez MM; von Schéele B; Hogue S; Kwong WJ Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283 [TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants in non-valvular atrial fibrillation. Potpara TS; Lip GY Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900 [TBL] [Abstract][Full Text] [Related]
14. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Becattini C; Vedovati MC; Agnelli G Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937 [TBL] [Abstract][Full Text] [Related]
15. Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients. Di Minno MN; Russolillo A; Di Minno A; Camera M; Parolari A; Tremoli E Expert Opin Emerg Drugs; 2013 Mar; 18(1):9-23. PubMed ID: 23448155 [TBL] [Abstract][Full Text] [Related]
16. Risk of stroke in patients with prior VKA or DOAC: A population-based real-world registry analysis. Mayer-Suess L; Rinner H; Lang W; Greisenegger S; Mikšová D; Gattringer T; Enzigner C; Sykora M; Vosko M; Mutzenbach JS; Ferrari J; Kiechl S; Knoflach M; Eur Stroke J; 2024 Jun; 9(2):418-423. PubMed ID: 38161290 [TBL] [Abstract][Full Text] [Related]
18. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209 [TBL] [Abstract][Full Text] [Related]
19. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation. Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272 [TBL] [Abstract][Full Text] [Related]
20. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]